---
title: Cardiac biomarkers prior to noncardiac surgery
date: '2024-06-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38829520/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240603181530&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Cardiac biomarkers, such as high-sensitivity cardiac troponin
  (hs-cTn) and brain natriuretic peptide (BNP) or N‑terminal prohormone of brain natriuretic
  peptide (NT-proBNP) are measured perioperatively to improve the prognosis and risk
  prediction. The European Society of Cardiology (ESC), European Society of Anesthesiology
  and Intensive Care (ESAIC) and the German Society of Anesthesiology and Intensive
  Care Medicine (DGAI) have recently published guidelines on the use of ...'
disable_comments: true
---
BACKGROUND: Cardiac biomarkers, such as high-sensitivity cardiac troponin (hs-cTn) and brain natriuretic peptide (BNP) or N‑terminal prohormone of brain natriuretic peptide (NT-proBNP) are measured perioperatively to improve the prognosis and risk prediction. The European Society of Cardiology (ESC), European Society of Anesthesiology and Intensive Care (ESAIC) and the German Society of Anesthesiology and Intensive Care Medicine (DGAI) have recently published guidelines on the use of ...